Biosion is a biotechnology company specializing in the development of innovative biologics, which are advanced medical treatments derived from living organisms. The company operates in the biopharmaceutical market, focusing on both preclinical and clinical stages of drug development. Biosion serves a diverse range of clients, including multinational pharmaceutical companies and healthcare providers, by offering cutting-edge biologics through its proprietary platforms. The business model is centered around a partnering approach, maximizing the value of its portfolio through strategic alliances and collaborations. Biosion generates revenue through research and development partnerships, licensing agreements, and commercial sales of its biologics. The company boasts a world-class team of experienced leaders who have successfully brought over 20 innovative biologics to the market globally. With a growing pipeline of more than 10 programs and nine partnerships to date, Biosion is well-positioned to make significant contributions to the biopharmaceutical industry.

Keywords: biotechnology, biologics, drug development, preclinical, clinical, partnerships, proprietary platforms, healthcare, pharmaceutical, innovation.